Tenet Healthcare CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
J Robert Kerrey, a Director of Tenet Healthcare Corp, sold 12,010 shares of common stock on September 14, 2026.
NYSE
Richard J Mark, a Director of Tenet Healthcare Corp, sold 10,000 shares of common stock on September 10, 2026 for $263.42 per share.
NYSE
Nadja West, a Director of Tenet Healthcare Corp, sold 1,152 shares of common stock on September 2, 2026 for $258.80 per share.
NYSE
Lisa Y Foo, EVP, Chief Operating Officer of Tenet Healthcare Corp, sold 24,000 shares of common stock on August 31, 2026 for $266.32 per share.
NYSE
Cecil D Haney, a Director of Tenet Healthcare Corp, reported a transaction in 150 shares of common stock on August 28, 2026.
NYSE
Cecil D Haney, a Director of Tenet Healthcare Corp, sold 1,300 shares of common stock on August 24, 2026 for $278.03 per share.
NYSE
Saumya Sutaria, CEO and a Director of Tenet Healthcare Corp, sold 100,000 shares of common stock on August 24, 2026.
NYSE
Tammy Romo, a Director of Tenet Healthcare Corp, sold 7,422 shares of common stock on August 6, 2026.
NYSE
Roy Blunt, a Director of Tenet Healthcare Corp, sold 600 shares of common stock on August 5, 2026 for $262.68 per share.
NYSE
Lisa Y Foo, EVP, Chief Operating Officer of Tenet Healthcare Corp, sold 10,000 shares of common stock on July 29, 2026 for $258.03 per share.
NYSE
Christopher S. Lynch, a Director of Tenet Healthcare Corp, sold 3,837 shares of common stock on July 27, 2026 for $243.44 per share.
NYSE
Paola M Arbour, EVP, Chief Information Officer of Tenet Healthcare Corp, sold 10,878 shares of common stock on July 27, 2026 for $243.90 per share.
NYSE
James L Bierman, a Director of Tenet Healthcare Corp, sold 5,000 shares of common stock on July 27, 2026 for $244.96 per share.
NYSE
Tenet Healthcare Director J. Robert Kerrey sold 5,638 shares of common stock on May 28, 2026.
NYSE
Director Vineeta Agarwala was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.
NYSE
Director Roy Blunt was granted 1,188 restricted stock units by Tenet Healthcare Corp as part of the company's stock incentive plan.
NYSE
Director Richard J. Mark was granted 1,188 restricted stock units as part of the Tenet Healthcare Corporation stock incentive plan.
NYSE
Tenet Healthcare Director Nadja West sold 3,000 shares of common stock while receiving a grant of 1,188 restricted stock units.
NYSE
Tenet Healthcare Director Richard W. Fisher was granted 1,188 restricted stock units as part of the company's incentive plan.
NYSE
Director Cecil D. Haney was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.
NYSE
Director James L. Bierman was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.
NYSE
Director Tammy Romo was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.
NYSE
Director Christopher S. Lynch was granted 1,188 restricted stock units as part of the company's stock incentive plan.
NYSE
Director J. Robert Kerrey was granted 1,464 restricted stock units by Tenet Healthcare Corporation.
NYSE
Director Meghan Fitzgerald was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.
NYSE
Director James L. Bierman of Tenet Healthcare Corp. acquired 1,333 shares of common stock through restricted stock units.
NYSE
Tenet Healthcare Corp. reports a Form 4 filing indicating Director Christopher S. Lynch acquired 1,333 shares of common stock.
NYSE
Tenet Healthcare Corp. Director Nadja West reported transactions involving common stock and restricted stock units.
NYSE
Tammy Romo, a Director at Tenet Healthcare Corp (THC), reported transactions involving common stock and restricted stock units.
NYSE
Richard W. Fisher, a Director at Tenet Healthcare Corp (THC), reported transactions involving restricted stock units and common stock.